The research focus of the Deshmukh group has centered on the development of data-driven computational methods for discovering new materials and small molecules. Through the development and application of computational frameworks that combine molecular simulation methods with machine learning models and algorithms, his research team has successfully identified and modified potential drug candidates (hits) for targeting SARS-CoV-2 and the Hepatitis E Virus (HEV).